TRANSCODE THERAPEUTICS INC (RNAZ)

US89357L3033 - Common Stock

0.82  +0.11 (+15.98%)

After market: 0.7813 -0.04 (-4.72%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
19.42M18.67M6.15M730.00K460.00K
Research and Development
12.26M10.23M2.75M280.00K230.00K
Selling, General, and Administrative Expenses
7.15M8.43M3.40M440.00K230.00K
Operating Income
-19.42M-18.67M-6.15M-730.00K-460.00K
Interest Income/Expense
-50.61K20.00K-960.00K-1.60M-150.00K
Other Income/Expense
923.04K1.08M270.00K-10.00K0.00
Income Before Taxes
-18.55M-17.56M-6.84M-2.34M-610.00K
Income Tax
N/AN/AN/A0.000.00
Net Income
-18.55M-17.56M-6.84M-2.34M-610.00K
EBITDA
-19.30M-18.57M-6.11MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-103.61-27.01-16.28-5.57-1.45
 
Statistics

All data in USD

Charts